Xun Zeng

5PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 18, 2026
A Novel Strategy to Produce CAR-γδ T Cells via Site-Directed Gene Integration by a Combination of CRISPR/Cas9 and AAV.

|Nov 17, 2025
Pre-Existing Th1 Immunity Outperforms Age in Predicting Antibody Responses to SARS-CoV-2 Inactivated Vaccines.

Chanyuan Ye, Xiaoli Zhang, Lingfeng Qiu

|Jan 31, 2024
CD57-positive CD8 + T cells define the response to anti-programmed cell death protein-1 immunotherapy in patients with advanced non-small cell lung cancer.

Wenjia Sun, Fengqi Qiu, Jing Zheng

|Dec 20, 2023
Cyclosporine A-resistant CAR-T cells mediate antitumour immunity in the presence of allogeneic cells.

Yixi Zhang, Hongyu Fang, Guocan Wang

|Feb 01, 2022
Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy.

Jiawei Shi, Junwei Liu, Xiaoxuan Tu

Pageof 1

Frequent Collaborators

1 joint publications

Wei Chen

1 joint publications

Weiwei Yin

1 joint publications

Weijia Fang

1 joint publications

Chun Zhou